Home›Immunology›Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
ImmunologyJoVE (Open Access)Citable · DOI
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
DOI: 10.3791/2459-v
What you'll learn
✓Prepare nanomaterials for in vivo imaging
✓Perform animal preparation for imaging
✓Acquire and analyze biodistribution data
✓Correlate imaging with histological results
Protocol
Biopharma Insights Bioimaging methods used to assess cell biodistribution of nanoparticles are applicable for therapeutic and diagnostic monitoring of nanoformulated compounds. The methods described herein are sensitive and specific when assessed by histological coregistration. The methodologies provide a translational pathway from rodent to human applications.
Difficulty
intermediate
Total time
~2-3 days including animal prep and imaging
Model organism
Rodent (mouse or rat)
Biosafety
BSL-1
Steps
1
Prepare nanomaterial formulations
Synthesize or label nanoparticles with imaging agents for subsequent injection.
▶ 04:05
2
Prepare animals for imaging
Anesthetize and position the animal to ensure stable imaging conditions.
▶ 05:26
3
Acquire imaging data
Use imaging system to collect signal from nanoparticles in vivo over time.
▶ 07:44
4
Analyze acquired imaging data
Process images to quantify nanoparticle distribution and signal intensity.
▶ 11:10
5
Review example imaging results
Compare observed results with representative examples for validation.
▶ 14:12
6
Conclude with translational implications
Summarize findings and discuss relevance for diagnostic and therapeutic monitoring.
▶ 15:06
💬 Comments coming soon
New protocols and pitfalls, in your inbox
A short email when we add notable lab videos and failure cases. No spam, unsubscribe anytime.